Expression of the p14ARF tumor suppressor predicts survival in acute myeloid leukemia.
D000208:Acute Disease; D000328:Adult; D000368:Aged; D001853:Bone Marrow; D016022:Case-Control Studies; D002453:Cell Cycle / Q000235:genetics; D016000:Cluster Analysis; D005260:Female; D020869:Gene Expression Profiling; D006801:Humans; D007951:Leukemia, Myeloid / Q000175:diagnosis* / Q000235:genetics / Q000401:mortality; D008297:Male; D008875:Middle Aged; D009687:Nuclear Proteins; D011379:Prognosis; D011518:Proto-Oncogene Proteins / Q000032:analysis / Q000235:genetics; D051736:Proto-Oncogene Proteins c-mdm2; D012334:RNA, Neoplasm / Q000032:analysis*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D016019:Survival Analysis; D025803:Tumor Suppressor Protein p14ARF / Q000032:analysis* / Q000235:genetics; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism
D009687:Nuclear Proteins; D011518:Proto-Oncogene Proteins; D012334:RNA, Neoplasm; D025803:Tumor Suppressor Protein p14ARF; D016159:Tumor Suppressor Protein p53; C497206:MDM2 protein, human; D051736:Proto-Oncogene Proteins c-mdm2